Published in Genetics on May 01, 1997
A statistical framework for quantitative trait mapping. Genetics (2001) 7.55
Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. Am J Hum Genet (1999) 4.54
Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci U S A (1998) 3.35
Enhanced efficiency of quantitative trait loci mapping analysis based on multivariate complexes of quantitative traits. Genetics (2001) 1.89
Joint estimates of quantitative trait locus effect and frequency using synthetic recombinant populations of Drosophila melanogaster. Genetics (2007) 1.78
Relaxed significance criteria for linkage analysis. Genetics (2006) 1.70
Defining a rat blood pressure quantitative trait locus to a <81.8 kb congenic segment: comprehensive sequencing and renal transcriptome analysis. Physiol Genomics (2010) 1.50
Mapping multiple Quantitative Trait Loci by Bayesian classification. Genetics (2004) 1.46
Single- and multiple-trait mapping analysis of linked quantitative trait loci. Some asymptotic analytical approximations. Genetics (1999) 1.25
Positional identification of variants of Adamts16 linked to inherited hypertension. Hum Mol Genet (2009) 1.21
Genetic mapping and genomic selection using recombination breakpoint data. Genetics (2013) 0.96
Influence analysis in quantitative trait loci detection. Biom J (2014) 0.75
A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity (Edinb) (1992) 55.23
Resolution of quantitative traits into Mendelian factors by using a complete linkage map of restriction fragment length polymorphisms. Nature (1988) 23.48
Interval mapping of multiple quantitative trait loci. Genetics (1993) 16.39
Effects of misspecifying genetic parameters in lod score analysis. Biometrics (1986) 6.36
Detecting marker-QTL linkage and estimating QTL gene effect and map location using a saturated genetic map. Genetics (1993) 5.24
Adequacy of single-locus approximations for linkage analyses of oligogenic traits. Genet Epidemiol (1992) 2.89
Model misspecification and multipoint linkage analysis. Hum Hered (1992) 2.80
Lods, wrods, and mods: the interpretation of lod scores calculated under different models. Genet Epidemiol (1994) 2.44
Asymptotic theory for gene mapping. Proc Natl Acad Sci U S A (1994) 1.62
On the asymptotic behavior of the estimate of the recombination fraction under the null hypothesis of no linkage when the model is misspecified. Genet Epidemiol (1990) 1.61
Guess LOD approach: sufficient conditions for robustness. Genet Epidemiol (1995) 1.37
Allegro, a new computer program for multipoint linkage analysis. Nat Genet (2000) 14.00
Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet (1999) 3.95
How medical professionals evaluate expressions of probability. N Engl J Med (1986) 2.51
Familial aggregation of Parkinson's disease in Iceland. N Engl J Med (2000) 2.41
Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med (2013) 2.22
The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97
Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet (2005) 1.91
Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia (1999) 1.91
Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med (2001) 1.89
Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet (1997) 1.87
Traditional knowledge about mushrooms in a Nahua community in the state of Tlaxcala, Mexico. Mycologia (2010) 1.85
Genetic factors contribute to the risk of developing endometriosis. Hum Reprod (2002) 1.42
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Assessing critical care unit performance: a global measure using graphical analysis. Anaesthesia (2002) 1.38
A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet (1999) 1.35
Blocking Gibbs sampling for linkage analysis in large pedigrees with many loops. Am J Hum Genet (1999) 1.31
Gender differences and regionalization of the cultural significance of wild mushrooms around La Malinche volcano, Tlaxcala, Mexico. Mycologia (2012) 1.30
Lumpectomy margins, reexcision, and local recurrence of breast cancer. Am J Surg (2000) 1.25
A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet (2001) 1.17
Hypercoagulability induced by crystalloids. Br J Anaesth (1996) 1.08
The genealogic approach to human genetics of disease. Cancer J (2001) 1.06
The Joint Asia Diabetes Evaluation (JADE) Program: a web-based program to translate evidence to clinical practice in Type 2 diabetes. Diabet Med (2009) 1.06
Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol) (2007) 1.00
Sequential imputation for multilocus linkage analysis. Proc Natl Acad Sci U S A (1994) 0.97
Diabetes, dependence, asymptotics, selection and significance. Nat Genet (1997) 0.92
Sclerosing mesenteritis. Australas Radiol (2005) 0.91
A simple risk score to identify Southern Chinese at high risk for diabetes. Diabet Med (2010) 0.91
Seasonal variation in admission rates to intensive care units. Anaesthesia (2001) 0.90
Anaesthesia, movement and emesis. Br J Anaesth (1990) 0.88
The role of linkage studies for common diseases. Curr Opin Genet Dev (2001) 0.88
Effects of finasteride on the rat ventral prostate. J Androl (1993) 0.87
PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits. Acta Biomater (2013) 0.86
Effects of 4-MAPC, a 5 alpha-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate. Prostate (1994) 0.83
Oculomotor control in calliphorid flies: GABAergic organization in heterolateral inhibitory pathways. J Comp Neurol (1995) 0.82
CDKN2A mutations and melanoma risk in the Icelandic population. J Med Genet (2008) 0.82
A model for the study of the oral administration of peptide hormones. Can J Biochem (1979) 0.81
Temozolomide as second-line chemotherapy for relapsed gliomas. J Neurooncol (2002) 0.80
Is corticotropin releasing factor modulated vasopressin? Nature (1980) 0.79
Naloxone has a direct effect on the adrenal cortex. Endocrinology (1981) 0.78
Heterogeneity in intensive care units: fact or fiction? Anaesthesia (1997) 0.78
Isolation, structure and synthesis of a heptapeptide with in vitro ACTH-releasing activity from porcine hypothalamus. Horm Metab Res (1981) 0.78
Computed tomography diagnosis of tracheobronchopathia osteochondroplastica. Australas Radiol (2005) 0.77
Infective endocarditis of the pulmonary valve following pulmonary artery catheterisation. Intensive Care Med (1994) 0.76
Airway obstruction caused by rheumatoid cricoarytenoid arthritis. Lancet (1998) 0.76
Inhaled prostacyclin as a selective pulmonary vasodilator. Anaesth Intensive Care (1996) 0.75
Genealogy certainly matters for multifactorial genetic disease. BMJ (1999) 0.75
On a randomization procedure. Am J Hum Genet (2000) 0.75
Properties of CRF from normal and Brattleboro rat median eminence. Neuroendocrinology (1982) 0.75
Effect of chlorpromazine on cyanide intoxication. Toxicol Appl Pharmacol (1983) 0.75
Prostatein C3-mRNA: a sensitive marker of androgen-responsiveness in prostate explant cultures. Prostate (1990) 0.75
Anti-androgen effects of the aromatase inhibitor, atamestane. J Androl (1995) 0.75
Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator. Am Rev Respir Dis (1990) 0.75
Radiopathological review of small bowel carcinoid tumours. J Med Imaging Radiat Oncol (2009) 0.75